Evidence map›Paper›PMID 27196089›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2016

Recommendations for Cancer Epidemiologic Research in Understudied Populations and Implications for Future Needs.

Damali N Martin, Tram Kim Lam, Katy Brignole, Kimlin T Ashing, William J Blot, Linda Burhansstipanov, Jarvis T Chen, Mark Dignan, Scarlett Lin Gomez, Maria Elena Martinez and 7 more

Abstract readEditorial
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Opportunities for Gene and Environment Research in Cancer: An Updated Review of NCI's Extramural Grant Portfolio.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2021
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Effect of a Digital Health Intervention on Decreasing Barriers and Increasing Facilitators for Colorectal Cancer Screening in Vulnerable Patients.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2020
    Article
  15. Article
  16. Article
  17. Considering religion and spirituality in precision medicine.Translational behavioral medicine · 2020
    Review
  18. Article
  19. Article
  20. Rural-Urban Differences in Cancer Incidence and Trends in the United States.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Damali N MartinDivision of Cancer Control and Population Sciences, National Cancer Institute, NIH, Bethesda, Maryland. martinda@mail.nih.gov.
Tram Kim LamDivision of Cancer Control and Population Sciences, National Cancer Institute, NIH, Bethesda, Maryland.
Katy BrignoleDivision of Cancer Control and Population Sciences, National Cancer Institute, NIH, Bethesda, Maryland.
Kimlin T AshingCenter for Community Alliance for Research and Education, City of Hope Cancer Center, Duarte, California.
William J BlotDivision of Epidemiology, Vanderbilt University School of Medicine, Nashville, Tennessee. International Epidemiology Institute, Rockville, Maryland.
Linda BurhansstipanovNative American Cancer Research Corporation, Denver, Colorado. Native American Cancer Initiatives, Incorporated, Colorado.
Jarvis T ChenDepartment of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Mark DignanMarkey Cancer Center, University of Kentucky, Lexington, Kentucky.
Scarlett Lin GomezCancer Prevention Institute of California, Fremont, California. Stanford Cancer Institute, Stanford, California.
Maria Elena MartinezDepartment of Family Medicine and Public Health, University of California, San Diego, La Jolla, California.
Alicia MatthewsSchool of Nursing, University of Illinois at Chicago, Chicago, Illinois.
Julie R PalmerSlone Epidemiology Center, Boston University, Boston, Massachusetts.
Eliseo J Perez-StableNational Institute on Minority Health and Health Disparities, National Institutes of Health, Bethesda, Maryland.
Mario SchootmanCollege for Public Health and Social Justice, Saint Louis University, St. Louis, Missouri.
Hugo VilchisBurrell College of Osteopathic Medicine/Burrell Institute for Health Policy & Research, Las Cruces, New Mexico.
Alexander VuDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Shobha SrinivasanDivision of Cancer Control and Population Sciences, National Cancer Institute, NIH, Bethesda, Maryland.

Funding

Southern Community Cohort StudyR01CA092447 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BLOT, WILLIAM J., ZHENG, WEI · 2001 to 2015
$74.0M
Intramural NIH HHS Z99 CA999999NCI NIH HHS R01 CA092447
6 · The paper itself

Abstract

Medically underserved populations in the United States continue to experience higher cancer burdens of incidence, mortality, and other cancer-related outcomes. It is imperative to understand how health inequities experienced by diverse population groups may contribute to our increasing unequal cancer burdens and disparate outcomes. The National Cancer Institute convened a diverse group of scientists to discuss research challenges and opportunities for cancer epidemiology in medically underserved and understudied populations. This report summarizes salient issues and discusses five recommendations from the group, including the next steps required to better examine and address cancer burden in the United States among our rapidly increasing diverse and understudied populations. Cancer Epidemiol Biomarkers Prev; 25(4); 573-80. ©2016 AACR SEE ALL ARTICLES IN THIS CEBP FOCUS SECTION, "MULTILEVEL APPROACHES TO ADDRESSING CANCER HEALTH DISPARITIES".

Indexed as

Epidemiologic StudiesHumansMinority GroupsNeoplasms

Identifiers

PMID27196089
PMCPMC4874661

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.